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Abstract
Background: Nowadays, small peripheral pulmonary lesions (PPLs) are frequently detected and the prognosis of
lung cancer depends on the early diagnosis. Because of the high fee and requiring specialized training, many
advanced techniques are not available in many developing countries and rural districts.
Methods: Three sets of opaque soft copper wires visible under the fluoroscopy (Flu) in the Flu-flexible
bronchoscopy (FB) group (n = 24), which determined the three planes of the lesion, were respectively placed
firmly on the surface of the chest wall with adhesive tape on the chest wall. The FB tip was advanced into
the bronchus toward the crosspoint of the three perpendicular planes under Flu with careful rotation of a C-arm unit.
Then the specimen were harvested focusing around the crosspoint for pathologic diagnosis. The rapid on-site
evaluation (ROSE) procedure was also performed. The average Flu time during FB procedures were recorded and
diagnostic accuracy rates in the Flu-FB group were compared with the other group guided by radial endobronchial
ultrasound (R-EBUS) (n = 23).
Results: The location of the core point of the lesion, whether it was visible or not under the fluoroscopy could
be recognized by three-dimensional localization technique. The accuracy rates of diagnostic yields were 62.5%
in the Flu-FB group, and was similar as 65.2% in the R-EBUS group (P > 0.05). However, in the Flu-FB group,
there was a decreasing tendency on accurate diagnosis rates of lower lobe (LL) lesions when comparing with
non-LL lesions (3/8 = 37.5% vs 12/16 = 75%, P = 0.091) while in the R-EBUS group it was similar (9/12 = 75% vs
6/11 = 54.6%, P = 0.278). In the Flu-FB group, fluoroscopy time was negatively correlated with the lesion
length (r = −0.613, P = 0.001), however, there was no significant difference between the lesions invisible or
not (5.83 ± 1.45 min vs 7.67 ± 2.02 min, P = 0.116) under the fluoroscopy, as well as no significant difference among
SPN, mGGO and GGO (6.12 ± 2.05 min, 7.25 ± 1.33 min and 7.80 ± 2.02 min, P > 0.05).
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Conclusions: Small PPL whether it is visible or not under fluoroscopy can be located accurately by our three-
dimensional localization technique on chest wall surface and performed bronchoscopy procedures to increase
diagnostic yields. It is more convenient, economical and reliable with the similar diagnostic yields than R-EBUS guided
method.
Trial registration: Current Controlled Trials ChiCTR-DDD-16009715. The date of registration: 3rd Nov, 2016.
Retrospectively registered.
Keywords: Small peripheral pulmonary lesions (PPLs), Invisible under fluoroscopy, Three-dimensional localization
technique, Opaque soft copper wires, Bronchoscopy, Diagnostic yields, Radial endobronchial ultrasound (R-EBUS),
Rapid on-site evaluation (ROSE)
Introduction
Nowadays, with the application of high-resolution com-
puted tomography (CT) imaging techniques to lung can-
cer screening, small solitary pulmonary nodule (SPN) or
ground-glass opacity (GGO) lesions in the lung are fre-
quently detected [1, 2]. For this article, the small periph-
eral pulmonary lesions (PPLs) are defined as lesions less
than 3 cm in length, including the SPN, GGO or mixed
GGO (mGGO) and being surrounded by the lung paren-
chyma without evidence of endobronchial abnormalities.
The differential diagnosis of PPN is broad, ranging from
benign tumors, edema, infectious lesions to lung cancer
and other malignant conditions [3]. Lung cancer is the
most common cause of cancer death for both men and
women with a 5-year global survival rate in patients in
the early stages of the disease of 38–67% and in later
stages of 1–8% [4]. Thus, the prognosis of lung cancer
depends on the early diagnosis of these lesions. When
biopsy is recommended, CT-guided transthoracic fine-
needle aspiration (TTNA) or biopsy is currently pre-
ferred because it has a diagnostic yield of 90%, although
perhaps less with smaller lesions [5]. However, TTNA
has limitations such as without bronchoalveolar lavage
fluid (BALF), brushing, and with respect to the puncture
site, seeding along the needle biopsy tract with malig-
nant cells which are potentially serious, with a risk from
0.06 to 1%, as well as a high risk of complications such
as a pneumothorax median 25% (range 4–60%), among
which 4% (range 0.2–8%) for pneumothorax requiring
chest tube and the median risk of hemorrhage is 12%
(range 2–66%), and may be higher in the diffuse lung
disease patients with bulla under pleura and those with
smaller nodules or nodules deep in the lung parenchyma
[6, 7]. Another more complex process video-assisted
thoracoscopic surgery (VATS), even CT assisted VATS
[8] is also an alternative method to obtain the tissue
samples especially for some small PPNs. However, some-
times the techniques need an additional tool such as O-
arm CT or some preoperative marking procedures to
identify the location of the small lesions [9, 10]. For ex-
ample, VATS involves hook-wire technique, endoscopic
ultrasonography, barium marking through bronchos-
copy, and percutaneous injections of dyes, colored colla-
gen, lipiodol, agar, and barium, et al. [7]. These methods
may also result in some complications mentioned above,
which led to its prohibition in Japan [11]. The diagnostic
yields of another diagnostic method, flexible bronchos-
copy, for PPLs <2 cm in the published reports have
varied from 5 to 28% [12]. Therefore, several guided-
bronchoscopy technologies have been developed to im-
prove the yields of transbronchial biopsy for PPLs diag-
nosis, such as real-time MSCT fluoroscopic guidance
with higher radiation doses to the patient and operators
[13], ultrathin bronchoscope, electromagnetic navigation
bronchoscopy (ENB), virtual bronchoscopy (VB), R-
EBUS with guide sheath (GS), and lung point [5, 14]. All
these methods have improved the diagnostic yields, for
example, the overall diagnostic yield of EBUS-GS-guided
transbronchial biopsy (TBB) may be 65.0% when the lo-
cation of the lesion can be confirmed by EBUS [9].
However, in many patients, the location of target le-
sion is invisible under the x-ray fluoroscopy and yet can
not always be identified so precisely by these guided-
bronchoscopy technologies and consequentially affect
the diagnostic yields. On the other hand, because of the
high fee of guided-bronchoscopy equipments and requir-
ing specialized training doctors, the advanced techniques
mentioned above are not always available for the hospi-
tals in many developing countries and rural districts.
Therefore, we are studying for a more convenient, eco-
nomical and reliable method for accurately locating the
small PPLs, then perform the bronchoscopy procedures
to improve the diagnostic yields. And we also perform
R-EBUS with GS for comparison.
Materials and methods
About the protocol
The protocol was approved by the University Ethics
Committee and the Institutional Review Board of the
First Affiliated Hospital of Fujian Medical University and
the First Hospital of Longyan City in Fujian Province.
Written informed consents prior to performing the
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procedure were obtained from all the enrolled patients
with the indications as follows: PPNs less than 30 mm in
diameter size. The patients with the contraindications
for the flexible bronchoscopy were excluded. All patients
were followed-up until achievements of definitive
diagnosis.
Groups
Patients from the two hospitals from June 2012 to
December 2015 were divided into 3 groups. All patients
underwent chest CT scanning using a multidetector CT
scanner (Aquilion; Toshiba; Tokyo, Japan) prior to bron-
choscopy, in order to locate the lung lesions at full in-
spiration. Images were reconstructed from helical CT
data by one radiologist and transferred to a work site.
Our new technique was performed on 24 lesions in 24
patients, we also named as fluoroscopy group, who were
classified into 2 groups: group1 (n = 12) and group2
(n = 12) according to the lesion visible or not under
fluoroscopy. The lesion visible or not was confirmed
by two radiologists. Visible lesion means the lesion
can be recognized under fluoroscopy by the both radiolo-
gists and invisible lesion means the lesion can not be rec-
ognized under fluoroscopy by the both radiologists.
However, if the lesion can not be recognized by one, then
should be confirmed invisible by the third radiologist. The
group 3 was performed EBUS-GS, namely Radial EBUS-
GS group.
Characteristics of patients
Among group 1 and 2, each lung lobe (including left lin-
gular) had lesion for confirming to locate accurately the
small PPNs. There were 12 patients with lesion visible
under fluoroscopy in the group 1 and also 12 patients
with lesion invisible under fluoroscopy in the group 2.
There were 23 patients in the group 3. The characteris-
tics of three groups were shown at Table 1.
Bronchoscopy procedures
Bronchoscope was advanced to segment where the lesion
located
Local anesthesia of the upper respiratory tract was
achieved using 2% lidocaine. Continuous pulse oximetry
was performed during FB, and blood pressure was
measured every 5 min. Oxygen was administered by a
nasal cannula, and the flow was adjusted upward from
2 L/min to maintain the pulse oximetric saturation
above 90%. After the FB (BF-1T260, Olympus, Tokyo,
Japan) was advanced beyond the vocal cords through the
nasal route, all segments of the bronchial tree were visu-
alized. Then the FB was advanced to the lesion segment
according to the CT scans. FB procedures were per-
formed by well-trained bronchoscopists who had more
than 10 years of experience. The average number of FB
procedures performed per year by the bronchoscopist
was 200 or greater.
Visible lesion under fluoroscopy
For the patients with PPN visible under fluoroscopy,
fluoroscopy-guided bronchoscopy was performed.
Lesions were located accurately by our techniques and
performed bronchoscopy procedures
Determing core point L of lesion according to cross-
point of three dimensions of lesion All chest CT scans
of the enrolled patients were reviewed to detect the lon-
gest diameter of three dimensions: length, width and
height of the lesion and the characteristics of the all le-
sions were carefully analyzed. The CT scans mainly aim-
ing at the lesion were reconstructed again with slices of
1 mm under a deep inspiratory breathhold. The bronchi
leading to the lesion were also recorded. A core point of
the lesion which we named as point L could be deter-
mined according to the crosspoint of the longest diam-
eter of three dimensions, that is length, width and height
of the lesion, on CT scans (Fig. 1a and b). Especially, if
the branches of bronchi leading into the lesion could be
recognized, the end point of the bronchi inside the le-
sion was determined as point L and also was recorded.
Point L could be reflected by crosspoint determined
by three planes lines on surface of chest wall Accord-
ing to the mathematical principle: Three Perpendicular
Planes Intersect at ONE Point, this Point can be







Age (years) 61 ± 18 58 ± 16 60 ± 15
Sex (cases)
Female 7 6 9
Male 5 6 14
Lesion size (mm)
Length 25.25 ± 3.05 13.00 ± 6.00 20.50 ± 5.00
Width 14.42 ± 4.81 9.42 ± 3.61 15.00 ± 4.30
Height 16.42 ± 2.31 7.33 ± 2.78 13.00 ± 6.50
Location and cases of each lobe
Right (left) upper lobe 2 2 6
Right middle (left lingular) lobe 2 2 5
Right (left) lower lobe 2 2 12
CT findings (Types and Cases)
GGO 0 5 5
mGGO 4 2 6
SPNs 8 5 12
Group 1: Patients with lung lesion visible under fluoroscopy; Group 2:
Patients with lung lesion invisible under fluoroscopy; Group 3: Patients
performed EBUS-GS
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reflected onto the surface of the chest wall by the three
perpendicular planes lines, that is Sagittal Plane A deter-
mined by Line a and Line a’, Coronal Plane B determined
by Line b and Line b’ and Horizontal Plane C determined
Hemicycle (or Whole Cycle) Line c (Fig. 1a and b). Ac-
cording to the CT parameters scanning the lesion, these
three perpendicular planes lines can be marked on the
surface of the patients’ chest wall (Clearly shown in Model
Fig. 2). Opaque soft wires, such as copper wires which
were visible under the fluoroscopy, were respectively
placed firmly on the surface of the chest wall with adhe-
sive tape according to the marks (Fig. 1c, d, e). Therefore,
although the lung lesion can not be recognized under the
fluoroscopy, the another crosspoint we named as L’ of the
three perpendicular planes determined by the three sets of
copper wires aa’, bb’ and hemicycle line c on the surface of
chest wall could reflect and fit accurately with the Point L
of the lung lesion (Fig. 1f).
Detecting accurately core point L of the lesion under
fluoroscopy Fluoroscopic guidance was provided by a
multipurpose C-arm type diagnostic unit (Allura Xper
FD20; Philipps Company; Amsterdam, the Netherlands).
With the careful rotation of a C-arm unit, we can see
the wires a and a’ overlapped together like one wire
named as Line A, and intersected with hemicycle c to-
ward the x-ray anteroposterior direction, which meaned
that Plane A intersected with Plane C at Line A. Then,
going on rotating the C-arm unit, we can also see the
wires b and b’ overlapped together like one wire named
as Line B, and intersected with hemicycle c toward the
x-ray horizontal direction, which meaned that Plane B
intersected with Plane C at Line B. As mentioned above,
the crosspoint L’ was also the crosspoint of Line A and
Line B. Therefore, we should advance the bronchoscope
tip into the bronchus toward the crosspoint of Line A
and Line B, which reflected the core point L of the le-
sion under the fluoroscopic guidance.
Harvesting specimen focusing around the point L of
the lung lesion The brush or forceps exserting from the
bronchoscopy reached the crosspoint L’ under the fluor-
oscopy. The specimen were harvested focusing around
Fig. 1 A core point of the lesion which we named as point L could be determined according to the crosspoint of the longest diameter of three
dimensions, that is length, width and height of the lesion, on CT scans (shown by a and b). Opaque soft copper wires were respectively placed
firmly on the surface of the chest wall with adhesive tape (shown by c, d and e). Under the fluoroscopy, with the careful rotation of the C-arm
machine, the crosspoint L’ of the three perpendicular planes determined by the three sets copper wires aa’, bb’ and hemicycle line c (shown by a
and b with bright pots and lines, and by f with dark lines) on the surface of chest wall could reflect and fit accurately with the Point L of the lung
lesion (shown by f)
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the point L of the lesion through the brushing, forceps
biopsy, and BALF.
ROSE
The rapid on-site evaluation (ROSE) procedure was
performed by a cytotechnologist after staining the
smears from the tissue obtained during the bronchos-
copy, enabling immediate cytopathologic evaluation
and feedback regarding specimen adequacy and po-
tential diagnosis. At least 2 smears were prepared,
one stained immediately with a rapid stain (Diff-Quik,
Baxter Diagnostics, Inc) and the other fixed in alcohol
for Papanicolaou (PAP) staining later. Cytologic slides
were then sent to the pathologist for immediate interpret-
ation of whether the sample was negative (no malignant
cells) or positive (definitive cytopathologic evidence of
malignancy) [15]. The remaining specimen was placed in
10% formaldehyde for routine histologic examination and
diagnosis.
Brief case report involving our techniques
A 75-year-old female with a 5-months’ history of recurrent
hemoptysis was admitted to the First Affiliated Hospital of
Fujian Medical University. The lung CT showed an
irregular shape nodule with 2.0 cm*2.0 cm*1.5 cm size in
the left posterior basal segment lobe (Fig. 3b, c). As
the principles and techniques mentioned above, the
core point of the lesion was determined. Then three
sets of metal wires were placed on the surface of the
patient’s chest wall. Although the lesion located be-
hind the heart and was hard to be recognized under
the fluoroscopy, the core point of the lesion was de-
tected with the help of our methods of locating lesion
(Fig. 3a, d). Subsequently, bronchoscopy procedures
under the fluoroscopy were done to harvest the speci-
men focusing around the core point of the lesion
(Fig. 3e, f ). The pathology from specimen showed
adenocarcinoma in situ with immunohistochemisty:
TTF-1, CK7, CK19, Napsina(+); PR, CEA(focal+); Tg,
Villion, CR, CK5/6, CDX-2, CA125, ER, GCDFP-15,
CK20, CA199(−), KI-67(+, 1%) (Fig. 3g).
EBUS procedures
In the group 3 (patients performed EBUS-GS), equipped
with endoscopic ultrasound system (EU-M30S, Olympus,
Tokyo, Japan), a 20 MHz radial small-diameter probe
(UM-S20–20R Olympus) with guide sheath was inserted
through the working channel of the bronchoscope. Once
Fig. 2 (model): According to the CT parameters scanning the lesion, the three perpendicular lines: Line a and a’ which determined Sagittal Plane
a, Line b and b’ which determined Coronal Plane b, and Hemicycle Line c which determined Horizontal Plane c can be marked on the surface of
the chest wall
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the precise location of the lesion was identified by EBUS,
the probe was withdrawn, leaving the GS in place. Subse-
quently, the specimen were harvested through the brush-
ing, forceps biopsy, and BALF for ROSE and pathologic
diagnosis as other groups.
Statistical analysis
Data were presented as mean ± standard deviation or
number (percent) as appropriate. Statistical analysis was
performed using χ2 test or Fisher’s exact test and t-test
in SPSS statistical software (SPSS version 15; SPSS;
Chicago, IL). A two-sided p value of less than 0.05 indi-
cated statistical significance.
Results
Results of patients performed bronchoscopy under
fluoroscopy
The location of the core point L of the lesion had
been determined in the chest CT scans. The point L
whether it was visible or invisible under the fluoros-
copy could be recognized by the crosspoint L’ of the
three perpendicular planes determined by the three
sets copper wires aa’, bb’ and hemicycle line c on the
surface of chest wall. The results of the patients per-
formed bronchoscopy under fluoroscopy were showed
in Table 2.
Visible lesion under fluoroscopy
Fluoroscopy-guided FB was advanced into the bron-
chus under fluoroscopic guidance according to the le-
sion location. The brushing, forceps biopsy and BALF
focusing on the lesion were performed in these pa-
tients (Fig. 4).
Results of patients performed bronchoscopy with
R-EBUS-GS
A total of 23 consecutive patients were included in the
study, with 9 female and 14 male. The detail characteris-
tics of this group were shown in group 3 in Table 1. The
mean age was 60 ± 15 years (range, 47 to 77 years). The
average lesion size in length was 20.50 ± 5.00 mm (range,
10 to 30 mm). Lesion was detected by the R-EBUS-
GS through FB according to its location (Fig. 5). The
accuracy rates of diagnostic yields were 65.2% (15 in
23 cases).
ROSE results
The cancer cells in the ROSE slides may show as:closter,
masslike and overlapped, scattered (Fig. 6). Scattered
cancer cells in the slides were prone to be ignored. Ac-
cording to whether the biopsy was successful and ad-
equate diagnostic material was harvested from initial
specimens, further specimens collection during bron-
choscopy (e.g. brushing, biopsy) will be performed or ad-
justed the biopsy sites [16].
Accuracy rates of diagnostic cases guided by fluoroscopy
guided FB or R-EBUS
The accuracy rates of diagnostic yields were 66.7% in the
group 1, 58.3% in the group 2, with average 62.5% in
these two groups (both were included in the fluoroscopy
group), and was similar as 65.2% in the group 3 (R-
EBUS-GS group) (P > 0.05). Accurate diagnosis rates
were similar among Flu-FB group and EBUS group (15
in 24 patients vs 15 in 23 patients, P = 0.846). In the Flu-
FB group, there were no significant difference among
different CT scan findings (P = 0.503) and whether the
Fig. 3 The lung CT showed an irregular shape nodule with 2.0 cm*2.0 cm*1.5 cm size in the left posterior basal segment lobe (b, c). Although
the lesion located behind the heart and was hard to be recognized under the fluoroscopy, the core point of the lesion was detected with the
help of our methods of locating lesion (a, d, shown within the white circle). Bronchoscopy procedures under the fluoroscopy were performed to
harvest the specimen focusing around the core point of the lung lesion (d, e, shown within the white circle). The pathology from the specimen
showed adenocarcinoma (f: ROSE, g: Histology)
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lesion visible or not under the fluoroscopy (P = 0.50).
However, in the Flu-FB group, there was a decreasing
tendency on accurate diagnosis rates of LL lesions
when comparing with non-LL lesions (3/8 = 37.5% vs
12/16 = 75%, P = 0.091) while in the EBUS group it
was similar (9/12 = 75% vs 6/11 = 54.6%, P = 0.278).
And in the EBUS group, there was a significant dif-
ference among different CT scan findings (P = 0.044)
with SPN vs GGO (P = 0.028) and whether the lesion
detectable or not by EBUS (P = 0.008) (Table 3).
Average fluoroscopy time during bronchoscope
procedures
In the fluoroscopy group (Flu-FB group), the average
fluoroscopy time was (6.75 ± 1.96) min. There were no
significant difference of the fluoroscopy time in lower
lobe patients compared with the not lower lobes patients
((6.75 ± 2.24) min vs (6.75 ± 1.88) min, P > 0.05). The
length of the visible lesion is much larger than the
invisible lesion (25.00 ± 2.92 mm vs 13.00 ± 6.00 mm,
F = 8.844, P = 0.007). Fluoroscopy time was negatively
correlated with the lesion length (r = −0.613, P = 0.001).
However, about fluoroscopy time, there was no significant
difference between visible lesion and the invisible lesion
(5.83 ± 1.45 min vs 7.67 ± 2.02 min, P = 0.116), as well as
no significant difference among SPN, mGGO and GGO
(6.12 ± 2.05 min, 7.25 ± 1.33 min and 7.80 ± 2.02 min,
P > 0.05).
Complications
There was 1 patient with the complication of minor
hemorrhage and 1 patient with pheumothorax not re-
quiring chest tube in group 2. No complication was
found in other groups.
Table 2 Results of patients performed bronchoscopy under fluoroscopy were shown
N Location CT finding Size (mm) Distance to
pleura (mm)




1 RUL mGGO 30*15*15 15 Visible Adenocarcinoma Adenocarcinoma 7.5
2 RLL SPN 12*10*11 10 Invisible Negative Adenocarcinoma 9.0
3 LM(L)L mGGO 18*15*10 8 Invisible Inflammation Inflammation 9.5
4 RLL SPN 25*15*14 18 Visible Inflammation? Adenocarcinoma 7.0
5 RML GGO 3*4*3 0 Invisible Negative Inflammation 10.0
6 LUL SPN 26*18*16 10 Visible Caseous necrosis Caseous necrosis 5.5
7 LUL SPN 25*11*15 5 Visible Carcinoma cells Adenocarcinoma 6.5
8 LLL SPN 9*8*5 10 Invisible Negative AAH 10.0
9 LUL GGO 4*3*3 15 Invisible Negative Inflammation 10.0
10 RML SPN 25*16*17 22 Visible Atypical cells AAH 4.5
11 LULΔ SPN 10*10*9 15 Invisible Squamous cell carcinoma Squamous cell carcinoma 8.0
12 LLL SPN 20*20*15 0 Visible Carcinoma cells Adenocarcinoma 7.5
13 RML mGGO 22*8*16 10 Visible Negative Adenocarcinoma 6.5
14 RUL SPN 20*8*6 20 Invisible Squamous cell carcinoma Squamous cell carcinoma 5.0
15 RUL mGGO 25*12*16 15 Visible Negative Caseous necrosis 5.5
16 RML GGO 11*13*7 20 Invisible Carcinomacells Small cell carcinoma 6.5
17 LM(L)L mGGO 30*11*20 0 Visible Poorly differentiated carcinoma Poorly differentiated carcinoma 7.5
18 RUL SPN 18*8*10 30 Invisible Carcinoma cells Squamous cell carcinoma 4.5
19 RLL SPN 25*15*22 28 Visible Small cell carcinoma Small cell carcinoma 4.0
20 RLL GGO 19*14*6 30 Invisible Negative Squamous cell carcinoma 6.0
21 LLL SPN 22*10*16 30 Visible Negative Inflammation 3.5
22 LM(L)L SPN 25*12*15 32 Visible Adenocarcinoma Adenocarcinoma 4.5
23 LLL* mGGO 20*10*8 35 Invisible Carcinoma cells Adenocarcinoma 7.0
24 LM(L)L GGO 12*10*10 25 Invisible Carcinoma cells Large cell carcinoma 6.5
N Number of cases, Visible:lesion can be recognized under fluoroscopy. Invisible:lesion can not be recognized under fluoroscopy. Visible or not: Visible or not
under fluoroscopy. Histology results from bronchoscopy include brushing, BALF and biopsies under fluoroscopy. Final diagnosis: histology pathological diagnosis
or diagnosis by following up. RUL Right Upper Lobe, RML Right Middle Lobe, RLL Right Lower Lobe, LUL Left Upper Lobe, LM(L)L Left Lingular Lobe, LLL Left Lower
Lobe, SPN Solitary Pulmonary Nodules, (m)GGO (mix) Ground Glass Opacity, AAH Atypical Adenomatous Hyperplasia. *:minor hemorrhage at the biopsy site;
Δ:pneumothorax not requiring chest tube
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Discussion
All of lung lesions shown by chest CT scans can be
successfully localized by our techniques
Lung cancer is currently the leading cause of cancer
deaths worldwide. The mortality rates have remained
high because of the difficulty in detecting early stage of
this disease. Fortunately, with the wide application of
HRCT, PPLs are frequently detected which made early
diagnosis become possible. However, using CT charac-
teristics alone to determine the lesions as benignity, pre-
malignancy or malignancy is often difficult [17]. The
tissue samples of the PPNs can be harvested by the FB.
The location of the lesion should be determined before
harvesting the samples, thus can improve the diagnostic
yield. The lung lesion location is estimated by chest
radiograph (CXR) or CT of the chest. It is a challenge to
determine the location of the small lesion, especially
which is invisible under the fluoroscopy.
However, whether the lung lesion is visible or not under
the fluoroscopy. The core point of the lesion detected by
CT scans can be reflected by the crosspoint of three planes
determined by the three sets of opaque soft wires placed
Fig. 4 Bronchoscopy procedures focusing on the visible lesion were performed under fluoroscopic guidance according to the lesion location.
a, Lesion was showed in Right Upper Lobe within circle. b, Lesion was showed in Left Upper Lobe within circle. c, Lesion was showed in Right
Lower Lobe within circle. d, Lesion was showed in Left lower Lobe within circle
Fig. 5 Lesions were detected by the R-EBUS-GS through bronchoscopy according to their locations in different lobes (Right lower lobe shown in
A and a; Right upper lobe shown in B and b; Left lower lobe shown in C and c; Left lingular lobe shown in D and d)
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on the surface of chest wall. According to the mathemat-
ical principle: Three Perpendicular Planes Intersect at
ONE Point, the lesion can be located accurately by our
techniques. Then, under the fluoroscopy, the bronchos-
copy procedures can be performed aiming at the cross-
point of the three perpendicular planes and the specimen
can be harvested by focusing around the point, which is
also the core point of the lung lesion. This technique does
not make use of sophisticated equipments, and it is easy
to be understood and mastered.
Performing bronchoscopy by our three-dimensional
localization technique
Accuracy rates of diagnosis by bronchoscopy whether
lesion is visible or not under fluoroscopy are similar
For non-endobronchial peripheral lung lesion, if the le-
sion is visible under fluoroscopy, the brush and biopsy
forceps of the bronchoscopy can be advanced into the
bronchus under fluoroscopic guidance according to the
lesion location, as been successfully performed in our
study. According to Rittirak et al. study, the overall diag-
nostic yield of Flu-TBLB group may be statistically sig-
nificantly higher than NFlu-TBLB group (43.8 vs. 32.9%;
P = 0.003) [18]. However, the diagnostic yields of FB for
peripheral pulmonary lesions <2 cm in published reports
have varied from 5 to 28%, because some lesions are
invisible through conventional flexible bronchoscopy
under fluoroscopy [12].
In our study, although lung lesion is invisible under
fluoroscopy, we can recognize it by the crosspoint of three
perpendicular planes determined by the opaque soft cop-
per wires placed on chest wall surface, therefore, the diag-
nostic yields have been improved, which is similar as R-
EBUS-GS group. And this location method will not be in-
fluenced by the different size, whether the lesion visible or
not under the fluoroscopy and CT scan characteristics of
the lesion, such as SPN, mGGO or GGO.
Accuracy rates of diagnosis by bronchoscopy of non-lower
lobe lesion are higher than lower lobe lesion
However, due to the respiratory motion, mainly caused
by the diaphragm motion, the lung lesion may be mislo-
calized [19]. Movement of the lung occurs with respira-
tory variation during bronchoscopy, and the location of
pulmonary nodule during procedures may differ signifi-
cantly from its location on the initial planning, especially
Fig. 6 The cancer cells in the ROSE slides may show as: closter (shown by a), masslike and overlapped (shown by b), scattered (shown by c and d)




Lesion location CT scan findings Lesion under fluoroscopy or EBUS
UL ML LL SPN mGGO GGO Visible Invisible
Flu-FB Cases enrolled 8 8 8 13 6 5 12 12
Accurate diagnosis 6 6 3 9 4 2 8 7
EBUS Cases enrolled 6 5 12 12 6 5 19 4
Accurate diagnosis 3 3 9 10 4 1 15 0
UL Upper lobe, ML Middle lobe, LL Lower lobe. Lesion under fluoroscopy or EBUS
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to the lower lobe, which moved significantly more than
upper lobe lesion. In the Flu-FB group of our study, a
decreasing tendency has been observed on accurate
diagnosis rates of LL lesions when comparing with non-
LL lesions, while in the EBUS group it was similar. Actu-
ally, one of the main challenges for us is hard to find the
exact position to perform a biopsy for the lesion located
in the lower lobe when respiratory motion. According to
the other studies, this movement during bronchoscopy
may even significantly affect the diagnostic yield of elec-
tromagnetic navigation bronchoscopy procedures [20].
The lesion size and distance from the pleura doesn’t sig-
nificantly impact the movement. Holding a deep breath
may manage the respiratory motion problem, but the
duration of bronchoscopy procedures which involve
BALF, biopsy, brushing et al., may take some longer
time. The navigation system with the proposed respira-
tory motion compensation method and EBUS allow for
real time guidance during bronchoscopic interventions,
and thus could increase the diagnostic yield [21]. There-
fore, combing with other diagnostic techniques may im-
prove diagnostic yields.
Diagnostic yield about R-EBUS
The technique of R-EBUS with a GS has definitely its
place in the diagnostic work-up of PPLs, especially for
the lesions that can be visualized by EBUS. The diagnos-
tic yield has fluctuated from 53% up to 77% [22], which
can be increased by ensuring that TBB is performed at
the correct location as identified by the EBUS. Tay et al.
performed a retrospective analysis of 196 consecutive
patients who underwent investigation with R-EBUS [23].
They found that a definitive diagnosis was established
for 109 PPL (56%) using radial EBUS. Visualized lesion
by EBUS probe had a higher diagnostic yield (65%) than
EBUS-invisible lesions (20%; P = 0.0001) and in multi-
variate analysis, lesion size, malignancy status and dis-
tance from hilum to lesion were significant predictors of
EBUS visualization yield. In our study, lesions performed
R-EBUS were visualized by EBUS probe and there were
same diagnostic yields as Tay et al’s study. On the other
hand, different CT scan findings have been associated
with different diagnostic yields bronchoscopy guided by
R-EBUS-GS, especially high with SPN lesion and low
with GGO lesion. However, the overall diagnostic yields
by R-EBUS-GS were similar with that by our three-
dimensional localization technique according to our
study. What we are concerned about is that the diagnos-
tic yield of EBUS-invisible lesions may be improved ac-
cording to our three-dimensional localization technique.
CT-guided transthoracic fine-needle aspiration
TTNA or biopsy is widely used currently for its high
diagnostic yields [5]. However, TTNA has a limitation
mentioned in the introduction part. Tai et al. has evalu-
ated the frequency and severity of pulmonary
hemorrhage after transthoracic needle lung biopsy
(TTLB) and assess possible factors associated with pul-
monary hemorrhage [24]. Tai et al. has found that the
pulmonary hemorrhage occurred in 483 of the 1175
TTLBs (41.1%) but rarely requires intervention and
higher-grade hemorrhage was more likely to occur with
female sex (P = 0.001), older age (P = 0.003), emphysema
(P = 0.004), coaxial technique (P = 0.025), nonsub-
pleural location (P < 0.001), lesion size of 3 cm or
smaller (P < 0.001), and subsolid lesions (P = 0.028).
However, to the lower lobe lesion, because of low ac-
curacy rates of diagnosis by our techniques, we rec-
ommend to perform CT-guided TTNA or combine
with other motheds to improve the diagnostic yield.
Role of ROSE
As we know, ROSE of tissue obtained by FNA has been
first introduced by Washington University investigators
in St. Louis, Missouri. Its major advantages have been
improvements in health care resource utilization, safety,
reduction in the number of sites biopsied, allowing im-
mediate processing and interpretation of the sample in
the procedural suite, lowering patient costs, increase of
sample adequacy rates and diagnostic yield, decrease x-
ray exposure time during radiologically guided interven-
tional procedures and other potential morbidity related
to the biopsy procedure [25–28], which has been re-
ported to have 85 to 93% sensitivity and 100% specificity
[29]. ROSE can also aim at molecular profiling (optimal
lung cancer genotyping) in patients with advanced lung
cancer [30]. Therefore, it is recommended to be per-
formed routinely, especially in patients with a suspected
diagnosis of lung cancer [31]. In our study, ROSE has
been performed in the 3 groups and the cancer cells
were found to be mainly distributed as :1) closter, 2)
masslike and overlapped, and 3) scattered. Scattered
cancer cells in the slides were prone to be ignored.
Therefore, the scattered characteristics of cancer cells
should be paid much more attention to. However, the
main reason for the scarcity of performing ROSE in
other practices is oftenly the lack of on-staff cytopathol-
ogists [32].
Fluoroscopy time in our study
It takes appropriated procedure time to perform bron-
choscope under fluoroscopy. There are a negative correl-
ation between the fluoroscopy time and the lesion
length. However, because the lesions can be located ac-
curately by our techniques and performed bronchoscopy
procedures, there is no significant difference on fluoros-
copy time between visible lesion and the invisible lesion,
as well as no significant difference among SPN, mGGO
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and GGO. Fluoroscopic guidance may be also utilized in
many other bronchoscopic procedures, including EBUS
for investigation of PPLs. Therefore, x-ray exposure
during radiologically guided interventional procedures
should be taken into consideration including the medical
staffs and patients. The fluoroscopy time in our study
was defined as the time from the lesion was nearly
reached by the bronchoscope to the biopsy time point.
With the help of ROSE in our study, the fluoroscopy
time is some shorter, comparing with Fujita Y et al’s
study [4]. However, Müller et al. reported that the dur-
ation of fluoroscopy time correlated with the radiation
dose to the hands of the surgeons, and that radiation
dose without thyroid protection was 70 times higher
than with thyroid protection in a comparison [33].
Therefore, the reduction of fluoroscopy time and proper
shielding of radiation doses are recommended.
Adverse effects
It is very convenient for us to use fluoroscopy to check
for adverse effects of pneumothorax and hemorrhage, to
confirm the position of the brush and forceps with open-
ing or not. Factors that were associated with the
increased risk of pneumothorax include patient charac-
teristics (age >60 years; COPD), lesion characteristics
(small size, greater distance from pleura), and technical
factors (increased number of punctures or aspirates, bi-
opsy performed in supine or lateral rather than prone
position). In our study, as one patient with pneumo-
thorax and one patient with minor bleeding, complica-
tions do exist [34].
It is recommended to combe with many diagnostic
techniques for increasing diagnostic yields
Many advanced bronchoscopy techniques have been
studied and performed in the patients with PPL, but as
clinicians, we should take these factors into consider-
ations: the choice of optimal investigation, determinants
of diagnostic yield for bronchoscopy, complications, and
practice pattern variations [34]. As mentioned above, the
accuracy of CT-guided lung biopsy is high. However, le-
sions that are smaller or deeper in the lung result in a
higher number of CT scans with increased radiation
dose and procedure time, seeding along the needle bi-
opsy tract with malignant cells and the lesions surround-
ing emphysema, lung bullae or pulmonary vascular, whic
are at high risk for pneumothorax or hemorrhage
following TTNA. Introducing the biopsy through the
bronchus within the target lesion increases the diagnos-
tic yield and also decreases the risk of pneumothorax
[35, 36 ]. When it is more difficult for the biopsy needle
to hit the lesion during CT-guided biopsy, it is more
likely for specimens to be retrieved and diagnosed from
the BALF and brushing guided by the brochoscopy with
the help of our three-dimensional localization technique
on chest wall surface. On the other hand, measuring and
applying the distance between the orifice of bronchus
and the lesion could increase the diagnostic yield of
EBUS-guided TBBs for PPLs [36]. According to our re-
sults, to non-lower lobe PPLs, performing bronchoscopy
by our three-dimensional localization technique may be
an optional selection, especially its convenient and eco-
nomical. And to lower lobe, we prefer to perform EBUS-
GS procedures.
Limitations of our study
Firstly, the number of the patients is not enough. Sec-
ondly, x-ray exposure to the medical staffs and patients
during radiologically guided interventional procedures
should be taken into much consideration, and the fluor-
oscopy time may be shorter after our proficiency on per-
forming the related procedures, for example performing
the ROSE and manipulating the C-arm unit. Thirdly,
there is no data about the combination ulities of diagnos-
tic methods, for example, three-dimensional localization
technique plus EUBS or/and CT-guided TTNA or biopsy.
Further studies focusing on these limitations are needed.
Conclusions
Small PPNs invisible under fluoroscopy can be located
accurately by our three-dimensional localization tech-
nique on chest wall surface and performed bronchos-
copy procedures to increase diagnostic yields. It is a
more convenient, economical and reliable method with
the similar diagnostic yields as R-EBUS guided method.
This localization technique can also be performed in
other organs such as the deep lesion of pancreas etc.
The ulities of multiple diagnostic methods are recom-
mended to increase diagnostic yields of PPLs according
to the equipments and specialized training available in
the hospitals.
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